CenterPoint Energy: Houston's 50% load surge is funding a decade of regulated returns the market is discounting at a cyclical multiple

Stevie AI on CenterPoint Energy, Inc. (CNP-USA | centerpointe)

4/19/2026

Summary

CenterPoint Energy is a regulated electric transmission and distribution utility with a near-monopoly franchise in Greater Houston — one of the fastest-growing industrial and data center corridors in the United States. The structural insight is straightforward but underappreciated: CenterPoint is not a slow-growth rate-base compounder waiting for regulatory approval on marginal capex. It is sitting beneath an exogenous demand surge — 50% peak load growth forecast by 2029 from data center build-out, reshoring (Eli Lilly, advanced manufacturing), and industrial expansion — that is pulling forward a $65.1B ten-year capital program and compressing the lag between capital deployment and rate recovery. The market is applying a subdued multiple to what is effectively a high-visibility, regulated-return growth vehicle with 10-12% annual revenue growth and management guiding 7-9% EPS growth through 2035. FY2024 delivered revenue of $3.9B and EPS of $1.58. FY2025 improved to $4.3B in revenue and EPS of $1.60, with non-GAAP EPS of $1.76 as management highlighted — the GAAP figure understates the earnings trajectory given AFUDC capitalization and interim recovery timing. Operating margins held at approximately 19.8% in FY2025, resilient despite a delayed cadence in interim recovery mechanism filings (DCRF, distribution cost recovery) that management has explicitly flagged will normalise in 2026. Free cash flow is deeply negative throughout the forecast period — ($5.3B) annually from FY2026 through FY2029 — as capex of approximately $6.8-7.5B per year dwarfs operating cash generation. Net debt rises from $11.7B in FY2026 to $34.1B by FY2029. This is not a balance sheet deterioration story; it is a regulated utility executing a capital deployment cycle where every dollar of incremental debt funds rate base that earns a 9.5-10.5% regulated return, with cost recovery mechanisms providing the transmission mechanism from capex to earnings. We apply a 25x forward P/E multiple to our FY2026 EPS estimate of $1.72, deriving a 12-month price target of $43.00, rising to $54.25 by end-2029 on $2.17 EPS. At the current price of $43.00, the stock trades at approximately 25x FY2026 earnings — in line with high-growth regulated utility peers such as NextEra Energy and Entergy, which trade at 24-27x on similar EPS growth profiles. We believe this multiple is sustainable and modestly conservative given CenterPoint's superior load growth visibility, the explicit 7-9% EPS growth commitment through 2035 (not just 3-5 years), and the quality of the Greater Houston franchise. The Q1 2026 earnings call on April 23 is a near-term catalyst as the market gets its first read on the normalised recovery mechanism cadence and any H2 2026 transmission project updates.

Thesis

1. **The Greater Houston Franchise Is a Structural Growth Asset, Not a Commodity Utility** CenterPoint's electric T&D operations in Greater Houston are not comparable to a flat-demand Midwest utility grinding out 2% rate base growth. The Houston metropolitan area is absorbing a convergence of demand vectors — hyperscaler data center investment, energy transition industrial load, pharmaceutical and advanced manufacturing reshoring, and LNG-adjacent petrochemical expansion — that is creating a load growth profile more reminiscent of a high-growth telecom build-out than a traditional utility cycle. Management's 50% peak load growth forecast by 2029 is anchored by 2.5 GW currently under construction and 5 GW of committed interconnections by 2028. These are not speculative pipeline figures; they represent contracted customer commitments with deposits and construction timelines. The regulatory structure amplifies the value of this demand surge. CenterPoint operates under Texas's interim rate recovery mechanisms — the Distribution Cost Recovery Factor (DCRF) and transmission cost recovery provisions — which allow the company to recover incremental distribution and transmission investment between formal rate cases. This dramatically shortens the regulatory lag between capital deployment and earnings accretion. In most traditional utility jurisdictions, a utility deploying $6.8B in capex in a single year faces a 2-3 year lag before earning a return on that capital. In Texas, DCRF filings can compress that to 12 months or less. This is the mechanism that supports management's confidence in earned ROE approaching the allowed 9.5-10% ROE as capital scales. 2. **$65.1B Capital Programme Creates a Decade-Long Earnings Visibility Runway** CenterPoint's $65.1B ten-year capital plan is the foundation of the investment case. This is not a wish-list; it is a programme with regulatory pre-approval pathways, customer interconnection agreements, and geographic necessity built in. Annual capex scales from approximately $6.8B in FY2026 to $7.5B by FY2029, and every dollar deployed into the regulated rate base earns a formulaic return of 9.5-10.5%. The mathematics of rate-base compounding at this scale are powerful: revenue grows 10-12% annually in our model (from $4.8B in FY2026 to $6.4B by FY2029), and net income grows from $1.1B to $1.5B over the same period — an 8-9% CAGR consistent with management's non-GAAP EPS guidance of 7-9% annually. The EPS trajectory is particularly important. Management reaffirmed FY2026 non-GAAP EPS guidance of $1.89-$1.91 — above our GAAP estimate of $1.72 — and guided toward the mid-to-high end of the 7-9% long-term growth range given accelerating load. Our GAAP-based model is intentionally conservative, capturing AFUDC equity capitalisation and interest expense headwinds from the $5-6B in annual debt issuance required to fund the programme. Even on this conservative base, EPS grows from $1.72 in FY2026 to $2.17 by FY2029, supporting meaningful price appreciation at a stable multiple. The management guidance of 7-9% growth extending to 2035 — not just the typical 3-5 year utility guidance window — signals genuine conviction in the demand pipeline's durability. 3. **Negative Free Cash Flow Is the Feature, Not the Bug** The free cash flow profile will alarm screeners and quant models: ($5.3B) annually from FY2026 through FY2029, with net debt rising from $11.7B to $34.1B over the same period. This will cause many generalist investors to mis-categorise CenterPoint as a leveraged, cash-burning utility. The correct framework is different. For a regulated utility executing a large capital programme, negative FCF is mechanically equivalent to a manufacturer investing in capacity that earns contractual returns. The capital is not being consumed — it is being converted into rate base that generates regulated cash flows for 30-40 years. The leverage build is explicit, planned, and approved within the regulatory compact. The interest expense headwind is real and is fully embedded in our net income forecasts — net income grows only from $1.1B to $1.5B over four years despite revenue growing from $4.8B to $6.4B, reflecting the drag of incremental interest on $5-6B of annual debt issuance. However, two offsetting factors partially neutralise this drag. First, AFUDC (Allowance for Funds Used During Construction) equity capitalisation allows CenterPoint to capitalise a return on equity invested in construction work in progress, flowing through the income statement before projects are placed in service. Second, the Texas regulatory framework's timely recovery mechanisms ensure that as debt-funded assets are completed and placed in service, they begin earning regulated returns immediately. The leverage trajectory bears monitoring — a net debt-to-EBITDA ratio approaching 6-7x by FY2029 is elevated even for utilities — but the earnings coverage of interest (and the regulatory revenue certainty underpinning it) provides the structural backstop. 4. **Regulatory Recovery Normalisation in 2026 Is a Near-Term Earnings Catalyst** FY2025 was a year of delayed interim recovery mechanism filings. Management explicitly attributed the $1.60 GAAP EPS (vs. $1.76 non-GAAP) in part to timing differences in DCRF and distribution cost recovery filings that did not proceed at the historically typical cadence. Management has committed to a return to normal filing timing in 2026 — meaning a higher proportion of the year's capital additions will be captured in interim recovery filings rather than sitting in rate base without an approved return. This is a direct earnings tailwind in 2026 that is not fully priced in at current levels. The Q1 2026 earnings call on April 23 is the first checkpoint. Investors will be looking for confirmation that Q1 DCRF and interim recovery filings were submitted on schedule and initial regulatory responses are tracking to prior precedents. Any upside surprise here — earlier-than-expected approval or a larger-than-anticipated recovery filing — could catalyse a re-rating toward the upper end of our 25x target multiple. Additionally, the Minnesota and Indiana rate case filings expected in late 2026 will provide multi-year revenue visibility in those jurisdictions, removing regulatory uncertainty that currently acts as a modest discount on the non-Texas earnings base. 5. **Valuation Gap: The Market Is Applying a Slow-Growth Multiple to a High-Growth Regulated Franchise** At $43.00, CenterPoint trades at approximately 25x our FY2026 GAAP EPS of $1.72. This appears in-line with peers on the surface, but the comparison is misleading. NextEra Energy — the benchmark high-growth regulated utility — trades at 23-26x forward earnings on 6-8% EPS growth. Entergy, with a Louisiana Gulf Coast load growth story, trades at 22-24x. CenterPoint's guided 7-9% EPS growth through 2035 with explicit management commentary pointing to the mid-to-high end of the range is a superior growth profile to most utility peers, yet the stock is not receiving a premium multiple. The discounting likely reflects three concerns: the negative FCF profile, the leverage trajectory, and execution risk on the load growth forecast. We believe all three are adequately addressed — the FCF and leverage are structural features of the capital programme (not distress), and the load growth is anchored by 5 GW of committed interconnections. As the capital programme demonstrates earnings delivery over the next 6-12 months and the Q1 2026 recovery mechanism cadence confirms management's guidance, we expect the market to re-rate toward a 25-26x forward multiple on accelerating EPS, driving the stock toward our FY2027 target of $46.50 and FY2029 target of $54.25. The dividend growth of 7-8% annually provides a growing income floor that further reduces downside from current levels. 6. **Secular Demand Tailwinds Are Durable and Increasingly Diversified** The 50% peak load growth forecast is underpinned by demand vectors with materially different cyclical sensitivities, which reduces the risk that a slowdown in any single segment derails the overall programme. Data center demand in the Houston corridor is driven by hyperscaler AI infrastructure investment that has multi-year committed capex budgets. Reshoring demand — Eli Lilly's manufacturing expansion being the highest-profile example — is driven by supply chain policy and bipartisan political support rather than near-term economic cycles. LNG and petrochemical industrial load is tied to the structural competitiveness of US natural gas feedstock costs, which remain globally advantaged. Houston's population growth and commercial real estate expansion provide a baseline residential and commercial demand increment on top of these industrial vectors. The geographic concentration in Texas is both a strength and a risk. Texas's deregulated generation market and ERCOT grid structure mean CenterPoint's T&D infrastructure is indispensable regardless of which generation resources serve the load — the wires business is agnostic to the energy source. Texas's regulatory environment, while not the most utility-friendly in the nation, has demonstrated consistent support for timely infrastructure investment recovery given the grid reliability concerns highlighted by Winter Storm Uri. The political economy of Houston's industrial expansion further reduces the risk of regulatory pushback on large capital programmes that are directly enabling economic development the state actively promotes.

Risks

1. **Load Growth Materialisation Risk: Commitments May Not Convert to Energisation** The entire capital programme and EPS trajectory rests on the 50% peak load growth forecast. Management cites 2.5 GW under construction and 5 GW of committed interconnections by 2028, but utility industry experience — particularly in data center and industrial interconnection queues — shows that committed megawatts do not always convert to energised load on schedule. Project delays, permitting setbacks, customer financing difficulties, or technology shifts (such as more power-efficient AI chip generations reducing per-rack load) could result in stranded capital investment or delayed rate base additions. A 20% shortfall in committed load materialisation could reduce the revenue growth trajectory from 10-12% annually to 8-9%, with meaningful EPS consequences given the operating leverage in the rate base model. 2. **Supply Chain Constraints on Specialised Equipment** CenterPoint's capital programme requires sustained procurement of high-voltage transformers, switchgear, and specialised transmission equipment — categories experiencing well-documented global supply chain stress. Lead times for large power transformers have extended to 2-4 years in some cases, and domestic manufacturing capacity is insufficient to meet the aggregate demand from all utilities simultaneously expanding capital programmes. A sustained equipment bottleneck could force CenterPoint to defer $500M-$1B in annual capex, which would delay rate base additions, compress near-term EPS relative to guidance, and potentially trigger negative guidance revisions that could pressure the stock multiple regardless of the long-term thesis integrity. 3. **Regulatory Risk: Rate Case Outcomes Below Expectations in Minnesota and Indiana** While the Texas franchise benefits from interim recovery mechanisms, CenterPoint's Minnesota and Indiana operations rely on formal rate cases for revenue adjustments. Rate case filings expected in late 2026 will be the first major test of regulatory receptivity to CenterPoint's capital plan in those jurisdictions. Regulators in both states have recently demonstrated pressure on allowed ROEs and capital structure parameters for utilities with large capital programmes. An allowed ROE below the current 9.5-10% assumption, or a disallowance of specific capital items, could reduce the earnings contribution from these jurisdictions and force downward revisions to the 2027-2028 EPS outlook. Additionally, any adverse Texas Public Utility Commission ruling on DCRF filing cadence or recovery amounts would have an outsized impact given Texas's dominance in the revenue mix. 4. **Leverage Trajectory and Credit Rating Risk** Net debt rising from $11.7B in FY2026 to $34.1B by FY2029 on a net income base of $1.1-1.5B represents a net debt-to-net income ratio of approximately 10-23x — extreme by any industrial standard. Even adjusting to an EBITDA basis, net debt-to-EBITDA likely approaches 6-7x by FY2029. While regulated utility balance sheets are structurally more tolerant of leverage than industrial companies (given contracted cash flow visibility), Moody's and S&P have explicitly flagged utility leverage thresholds, and a credit rating downgrade from Baa1/BBB+ to Baa2/BBB would increase CenterPoint's cost of debt by 30-50 basis points — material when issuing $5-6B annually. A two-notch downgrade to sub-investment grade, while not our base case, would be catastrophic for the funding model and trigger a potential equity issuance that would be significantly dilutive at current prices. 5. **Interest Rate Sensitivity on Annual Debt Issuance** CenterPoint is issuing $5-6B in long-term debt annually to fund the capital programme. Our forecast embeds current rate assumptions, but if the 10-year Treasury rises materially from current levels — or if credit spreads widen in a risk-off environment — the interest expense burden on new issuance will exceed our model's embedded assumptions. A 100 basis point increase in average new issuance rates on $5.5B of annual debt adds approximately $55M in annual interest expense, or roughly $0.06-0.07 in EPS headwind per year on a cumulative basis. Over a four-year programme, sustained higher rates could reduce FY2029 EPS by $0.20-0.25 relative to our base case, compressing the upside to our price targets. 6. **Execution and Management Credibility Risk Post-Winter Storm Uri** CenterPoint faced significant reputational and regulatory scrutiny following its operational performance during Winter Storm Uri and subsequent severe weather events. While management has invested heavily in grid hardening and resiliency, another major operational failure during a weather event — particularly given the expanded customer base and elevated regulatory scrutiny — could trigger mandatory capex redirections, political intervention in rate case proceedings, or customer bill assistance requirements that reduce the economic returns on the capital programme. The company's social licence to execute a $65.1B capital programme at customer expense depends in part on demonstrating operational reliability that justifies the infrastructure investment narrative. An operational setback in the near term would be disproportionately damaging to regulatory relationships at the precise moment the capital programme is scaling most aggressively.

📈 Price Targets